ABSTRACT Intra-aortic balloon pump (IABP) is commonly used as mechanical support after cardiac surgery or cardiac shock. Although its benefits for cardiac function have been well documented, its effects on cerebral circulation are still controversial. We hypothesized that transfer function analysis (TFA) and continuous estimates of dynamic cerebral autoregulation (CA) provide consistent results in the assessment of cerebral autoregulation in patients with IABP.
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Introduction
Intra-aortic balloon pump (IABP) is commonly used as mechanical support after cardiac surgery or cardiac shock (Baskett et al 2002 , Boning et al 2013 , Jobs et al 2015 . Although its benefits for improving cardiac function have been well documented, its effects on the cerebral circulation are still controversial (Yang et al 2014) . Given on-going concerns about the effects of cardiac surgery on cognitive impairment and perioperative hypoperfusion stroke, the role of IABP on alterations of cerebral haemodynamic parameters is of considerable interest (Nadelson et al 2014 , Saczynski et al 2012 , Salazar et al 2001 .
The main reason why IABP might disturb cerebral blood flow (CBF) and/or its regulatory mechanisms, is due to observed changes in CBF temporal patterns, including the occurrence of transient reversed diastolic (i.e. negative) values of CBF, or CBF velocity (CBFV) recorded with transcranial Doppler ultrasound ( Fig. 1 ) (Brass 1990 , Schachtrupp et al 2005 , Schutt et al 2016 . Chiefly amongst these regulatory mechanisms, is cerebral autoregulation (CA) that maintains cerebral perfusion within strict limits despite changes in mean arterial blood pressure (BP) in the range 60-150mmHg (Panerai 1998 , Paulson et al 1990 .
Disruption of CA has been associated with several cerebrovascular conditions such as stroke, head injury, pre-eclampsia, neonatal prematurity, ischemic heart disease, and autonomic nervous system failure (Beek et al 2008 , Caldas et al 2017 , Claassen et al 2016 , Ma et al 2016 , Panerai 2008 , Panerai et al 1995 , Salinet et al 2014 , Veen et al 2015 . Hypoor hyper-perfusion, resulting from disturbances in CA are thought to be contributing factors in the neurological complications following cardiac surgery with cardiopulmonary bypass (CPB) (Hori et al 2014 , Ono et al 2013 and the use of IABP could also play a part in the development of these complications. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   Page 4 of 28  AUTHOR SUBMITTED MANUSCRIPT -PMEA-101803.R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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With potentially major changes in the temporal patterns of BP and CBF, the applicability of classical methods for assessment of CA during IABP cannot be taken for granted. CA can be assessed by either static or dynamic techniques (Tiecks et al 1995) . Both approaches, either using steady-state values of BP (static) or the transient CBFV response to rapid changes in BP (dynamic), rely on linear models using BP as input and CBF as output. By far, the most common of these methods is transfer function analysis (TFA) of spontaneous fluctuations in BP and CBF that does not require any special maneuvers to obtain estimates of dynamic CA at rest (Claassen et al 2016) . The assumption that TFA should also be applicable to patients with IABP though, cannot be accepted a priori as the altered CBF waveforms might indicate the occurrence of highly non-linear phenomena such as transient vessel collapse. The present study has benefited from an opportunistic sample of recordings obtained as part of a larger study on the effectiveness of IABP, containing continuous measurements of BP and CBFV during IABP removal. By examining the behavior of dynamic CA and other cerebrovascular parameters, we have been able to test the hypothesis that despite changes in CBFV waveforms, IABP does not disturb cerebral hemodynamics. The relevance of the study then, is to certify that TFA and continuous estimates of dynamic CA are acceptable methods to assess cerebral hemodynamics in patients with IABP, as a precondition to larger studies on the short-and long-term effects of this device on the cerebral circulation.
Methods

Subjects
This was an observational study, performed at the Heart Institute of the University of São Paulo from May 2014 to July 2015. Patients were considered eligible to participate in the study if they fulfilled the following criteria: (i) aged older than 18 years, (ii) submitted to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   Page 5 of 28  AUTHOR SUBMITTED MANUSCRIPT -PMEA-101803.R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 6 elective coronary artery bypass graft surgery (CABG) with CPB and intra-operative prophylactic IABP, (iii) written informed consent. The study was approved by both the institutional review board of the hospital and the local research ethics committee (ref.
835.731).
Measurements
Following surgery, participants were at rest, lying in a supine position (30°) and clinically stable. Measurements were performed over 5 minutes with the IABP operating with a 1:3 ratio, that is one inflation every three cardiac cycles, triggered by the electrocardiogram (Schachtrupp et al 2005) . A second measurement was performed for 5 minutes, starting one minute with IABP ON, continuing through removal of the IABP for another four minutes without pumping assistance (IABP OFF).
Data acquisition
Bilateral simultaneous TCD evaluation of the middle cerebral arteries (MCAs) was carried out using 2 MHz pulsed, range-gated probes (DWL, Dopplerbox, Germany), held in place using a head frame. If only one MCA could be found, that one side was used in the analysis.
The insonation depths varied from 50 to 55 mm, with slight anterior angulation (15-30°) of the probe through the temporal window. BP was continuously measured invasively with an intra-arterial line (Philips Monitor MP50, Germany).
End-tidal CO 2 (EtCO 2 ) was continuously measured with an infrared capnograph (Dixtal, dx 1265 ETCO 2 Capnogard, Manaus, Brazil) via a closely fitting mask and was documented at 1 min intervals. A c c e p t e d M a n u s c r i p t 7 Signals were sampled at a rate of 100 Hz and stored on a dedicated personal computer for offline analysis. Data editing and parameter extraction were performed as described previously (Salinet et al 2012) . In brief, recordings were visually inspected, the BP signal was calibrated, and narrow spikes (<100 ms) and artefacts were removed by linear interpolation. Subsequently, all signals were filtered in the forward and reverse direction using an eighth-order Butterworth low-pass filter with a cut-off frequency of 20 Hz. The beginning and end of each cardiac cycle were detected from the BP signal, and mean values of BP, CBFV and heart rate were obtained for each heart beat. Critical closing pressure As demonstrated elsewhere (Panerai et al 2010), the ARMA coefficients and their Walsh decomposition coefficients can be estimated by least-squares. Once these are available, the CBFV step response can be calculated at each time interval along the recording, and at that point the ARI t can be obtained with optimal fitting of one of the 10 template curves proposed
Data analysis
by Tiecks et al (1995) . The ARI t and all other cerebral hemodynamic parameters were averaged for 10s before removal of IABP (T1), 1 minute after removal (T2) and 3 minutes after removal of the device (T3). A c c e p t e d M a n u s c r i p t 9 ranges [IQRs] . Inter-hemispherical differences in parameters were tested with the paired Student's t-test or Wilcoxon non-parametric test. In the absence of differences, values for the right and left MCAs were averaged. Changes at T1, T2 and T3 were assessed with a 1-way repeated measures ANOVA (parametric) or Friedman test (non-parametric). Statistical analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, IL). A p-value < 0.05 was considered statistically significant.
Statistical analysis
Results
Good quality recordings were obtained for 14 patients (10 male) aged 63.9 ± 7.9 years. 
Cerebral hemodynamic parameters and dynamic CA during baseline
None of the bilateral parameters (CBFV, CrCP, RAP, and ARI) showed significant differences between the right and left MCAs and for this reason were averaged in further analyses. ARI t is reported separately for each hemisphere. A c c e p t e d M a n u s c r i p t 10 differences, like systolic BP, ICC (Table 1) was correspondingly low, but in other cases it is in agreement with the literature as discussed below.
Despite the distorted waveforms (Fig. 1) , CrCP and RAP estimated with the first harmonic method reflected velocity-pressure curves for IABP ON and OFF that were almost superimposed, as illustrated in Fig. 2 .
Transfer function analysis parameters for the two assessment periods are given in Table 1 and Fig. 3 . ARI values with IABP ON (4.3 ± 1.2) were not significantly different from corresponding values at IABP OFF (4.7 ± 1.4, p= 0.42) as suggested by the CBFV step response plots in Fig. 3D . None of the other TFA parameters showed statistically significant differences (Table 1 , Fig. 3 ).
Cerebral hemodynamic and dynamic CA during weaning of IABP.
None of the cerebral and peripheral hemodynamic parameters assessed showed differences for the three time-points considered (T1-T3) during withdrawal of IABP (Table 2) , despite the visual suggestion of potential trends in Fig. 4 .
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Our study had some limitations. First, TCD cannot provide absolute measurements of CBF, the use of CBFV as a surrogate relies on the assumption that the MCA diameter remains approximately constant. This is likely to be the case during 5-minute baseline measurements obtained at rest, without large fluctuations in PaCO 2 as was the case of our study (Coverdale et al 2014) . Secondly, the fact that we have only studied patients with IABP inflation ratios of 1:3 means that our conclusions cannot be automatically extended to other operating modes, such as 1:1 and 1:2 ratios. Nonetheless, it is known that the waveform pattern of cerebral blood flow is similar in all three ratios (Cheung et al 1998) . Thirdly, Fig. 4 gives visual indication of a drop in BP around 60s after removal of IABP and in ARI t around A c c e p t e d M a n u s c r i p t
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Conclusion
The current study has demonstrated the feasibility of TFA to analyse changes in the pattern of CBFV response and ARI during the removal of the IABP device. Our findings have important implications for the design of studies of critically ill patients requiring the use of different invasive support devices. In particular, confirming the ability to undertake cerebral hemodynamic assessment and to investigate the potential contribution of peripheral and cerebral hemodynamic perturbations to short-and long-term neurological consequences of cardiac surgery.
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